Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Psychopharmacology (Oxford, England)|February 22, 2024
The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysisArman Shafiee, Razman Arabzadeh Bahri, Mohammad Ali Rafiei, et al.
European Journal of Medical Research|August 9, 2023
Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysisArman Shafiee, Mohammad Javad Amini, Razman Arabzadeh Bahri, et al.
Urology Journal|November 19, 2025
Long Non Coding RNAs as Prognostic Factors or Diagnostic Biomarkers of Renal Transplant Rejection: A Systematic Review and Meta AnalysisLeila Zareian Baghdadabad, Razman Arabzadeh Bahri, Parnian Shobeiriand, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|December 20, 2023
Is skin autofluorescence a novel non-invasive marker in diabetes? A systematic review and meta-analysis of case-control studiesMahboobeh Sadat Hosseini, Zahra Razavi, Razman Arabzadeh Bahri, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 5, 2023
Pain management following septorhinoplasty surgery: evidence from a systematic reviewArman Shafiee, Razman Arabzadeh Bahri, Mohammad Mobin Teymouri Athar, et al.
International Clinical Psychopharmacology|April 19, 2024
Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trialAhmad Shamabadi, Hanie Karimi, Mohammad Ali Fallahzadeh, et al.
Urology Journal|November 19, 2025
Machine Learning-Based Prediction of Urolithiasis Recurrence Using Patient's Clinical Data, Demography, and CT FindingsHassan Homayoun, Seyed Jalaleddin Mousavirad, Leila Zareian Baghdadabad, et al.
Psychiatry and Clinical Neurosciences|October 2, 2024
Naproxen adjunct to fluoxetine for moderate-to-severe obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trialAhmad Shamabadi, Zahra Motavalian, Yalda Farahmand, et al.
Pageof 5